1
Bruce D Cohen, Jean Beebe, Penelope E Miller, James D Moyer, Jose R Corvalan, Michael Gallo: Antibodies to insulin-like growth factor I receptor. Abgenix, Pfizer, Fish & Neave IP Group Ropes & Gray, James F Haley Jr Esq, Jane T Gunnison Esq, May 2, 2006: US07037498 (40 worldwide citation)

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...


2
Bruce D Cohen, Jean Beebe, Penelope E Miller, James D Moyer, Jose R Corvalan, Michael Gallo: Antibodies to insulin-like growth factor I receptor. Amgen Fremont, Pfizer, Ropes & Gray, Jane T Gunnison, Z Ying Li, April 20, 2010: US07700742 (5 worldwide citation)

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...


3
Bruce D Cohen, Jean Beebe, Penelope E Miller, James D Moyer, Jose R Corvalan, Michael Gallo: Antibodies to insulin-like growth factor I receptor. Amgen Fremont, Pfizer, Ropes & Gray, Jane T Gunnison, Z Ying Li, October 19, 2010: US07815907 (3 worldwide citation)

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...


4
Bruce D Cohen, Jean Beebe, Penelope E Miller, James D Moyer, Jose Ramon Corvalan, Michael Gallo: Antibodies to insulin-like growth factor I receptor. Amgen Fremont, Pfizer, Ropes & Gray, Jane T Gunnison, Z Ying Li, July 19, 2011: US07982024 (1 worldwide citation)

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...


5
Bruce D Cohen, Jean Beebe Jr, Penelope E Miller, James D Moyer, Jose Ramon Corvalan, Michael Gallo: Antibodies to insulin-like growth factor I receptor. Pfizer, Amgen Fremont, Knobbe Martens Olson & Bear, January 12, 2016: US09234041

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...


6
Bruce D Cohen, Jean Beebe, Penelope E Miller, James D Moyer, Jose Ramon Corvalan, Michael Gallo: Antibodies to insulin-like growth factor I receptor. Amgen Fremont, Pfizer, Ropes & Gray, Jane T Gunnison, Z Ying Li, February 4, 2014: US08642037

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...


7
Bruce D Cohen, Jean Beebe, Penelope E Miller, James D Moyer, Jose R Corvalan, Michael Gallo: Antibodies to insulin-like growth factor I receptor. Fish & Neave, May 6, 2004: US20040086503-A1

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...


8
Diane Healey, Jean Beebe, James J O Leary, W Gregory Roberts, Anthony Tolcher, Mark S Huberman: Combination therapy to prevent and treat diarrhea induced by cancer treatment. Pfizer, Pfizer, November 3, 2005: US20050245456-A1

This invention relates to a method of treating drug side effects in cancer treatment. More particularly, the present invention relates to preventing, reducing, alleviating, or reversing diarrhea caused by the administration of the isothiazole 3-(4-Bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-y ...


9
Bruce D Cohen, Jean Beebe, Penelope E Miller, James D Moyer, Jose R Corvalan, Michael Gallo: Antibodies to insulin-like growth factor I receptor. Pfizer, Abgenix, Fish & Neave Ip Group, Ropes & Gray, December 22, 2005: US20050281812-A1

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...


10
Bruce D Cohen, Jean Beebe, Penelope E Miller, James D Moyer, Jose R Corvalan, Michael Gallo: Antibodies to insulin-like growth factor i receptor. Amgen Fremont, Pfizer, Ropes & Gray, October 7, 2010: US20100255538-A1

The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to insulin-like growth factor I receptor (IGF-IR), which is preferably human IGF-IR. The invention also relates to human anti-IGF-IR antibodies, including chimeric, bispecific, derivatized, single ...